Malignant Oral Cavity Neoplasm
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Oral Cavity Neoplasm trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Oral Cavity Neoplasm trials you may qualify forImaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are…
In this clinical trial, symptom monitoring (interactive voice response \[IVR\] is compared to automated telephone symptom management \[ATSM\] and telephone inte…
An open-label, first-in-human, Phase 1 study in adult patients with relapsed advanced malignancies will be done to assess AUR107 safety, tolerability, pharmacok…
This phase II trial studies the effect of larotrectinib in treating patients with NTRK gene amplification positive solid tumors that have spread to nearby tissu…
This clinical trial studies the effect of customized 3 dimensional (3D) printed oral tents on patients with head and neck cancer who are receiving radiotherapy.…
This phase II trial studies if talazoparib works in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or dist…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
This phase I trial studies the side effects and best dose of ropidoxuridine when given together with whole brain radiation therapy in treating patients with can…